Filing Details
- Accession Number:
- 0001683168-23-002495
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-18 08:00:05
- Reporting Period:
- 2023-04-17
- Accepted Time:
- 2023-04-18 08:00:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1729427 | Cns Pharmaceuticals Inc. | CNSP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1705978 | Christopher Downs | C/O Cns Pharmaceuticals, Inc. 2100 West Loop South, Suite 900 Houston TX 77027 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-17 | 3,100 | $3.20 | 9,251 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
